Countries need greater support and less stringent conditions if global fund goals are to be met

July 01, 2004

The London School of Hygiene & Tropical Medicine (LSHTM) will today publish interim findings relating to how the Global Fund to Fight AIDS, Tuberculosis and Malaria is being implemented in four African countries. The Fund was established in 2002 as a mechanism to get additional resources to affected countries to control these devastating diseases.

The findings, which appear in the Lancet, are based on interviews with 137 national level respondents. They reveal that the conditions set by the Global Fund around performance-based payments will be difficult for fund recipients and sub-recipients to meet, and that the Fund's goals may be threatened as a result. They also indicate that delays in getting funds to those who will use them have frustrated hopes of a quick scaling-up of disease control interventions.

The paper's lead author, Ruairí Brugha, Senior Lecturer in Public Health at LSHTM, comments: 'The Global Fund is one of several new global initiatives to finance HIV/AIDS control, each superimposed on the systems which already exist in the countries being targeted. What our interim findings show is that the Global Fund's goals will only be met if there are clearer guidelines, significant improvements in co-ordination among donors, and with simpler and more straightforward funding, planning, management and reporting systems'.
-end-


London School of Hygiene & Tropical Medicine

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.